NCT00138502

Brief Summary

The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
926

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2001

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 17, 2001

Completed
3.9 years until next milestone

First Submitted

Initial submission to the registry

August 26, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 30, 2005

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2008

Completed
Last Updated

February 4, 2019

Status Verified

October 1, 2007

Enrollment Period

7.2 years

First QC Date

August 26, 2005

Last Update Submit

January 31, 2019

Conditions

Candidiasis

Keywords

Candidiasis, Funguria

Eligibility Criteria

AgeUp to 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects with fungi isolated from the urine of any colony count.
  • Patients seen at either Harbor-UCLA Medical Center or Cedars Sinai Medical Center.

You may not qualify if:

  • \. Persons with a previously positive urine fungal culture during the current hospital admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cedars Sinai Medical Center

Los Angeles, California, 90048, United States

Location

UCLA Center For Vaccine Research

Torrance, California, 90509, United States

Location

MeSH Terms

Conditions

Candidiasis

Condition Hierarchy (Ancestors)

MycosesBacterial Infections and MycosesInfections

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
NIH

Study Record Dates

First Submitted

August 26, 2005

First Posted

August 30, 2005

Study Start

September 17, 2001

Primary Completion

December 8, 2008

Study Completion

December 8, 2008

Last Updated

February 4, 2019

Record last verified: 2007-10

Locations

US(2)